Cargando…

Digital health for allergen immunotherapy

In the recent past, digital healthcare technologies are experiencing a significant leap in development, with an additional unforeseen acceleration in implementation due to the SARS-CoV-2 pandemic. The increased use of mobile applications as well as communication technologies to search for services a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dramburg, Stephanie, Matricardi, Paolo Maria, Pfaar, Oliver, Klimek, Ludger
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dustri-Verlag Dr. Karl Feistle 2022
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9746244/ https://www.ncbi.nlm.nih.gov/pubmed/36523960 http://dx.doi.org/10.5414/ALX02301E

Ejemplares similares

Clinical endpoints in allergen immunotherapy: State of the art 2022
por: Gerth van Wijk, Roy, et al.
Publicado: (2023)

Use of telemedicine by practising allergists before and during the SARS-CoV-2 pandemic: A survey among members of the Association of German Allergists (AeDA)
por: Dramburg, Stephanie, et al.
Publicado: (2021)

Nutzung telemedizinischer Anwendungen durch niedergelassene Allergologen vor und während der SARS-CoV-2-Pandemie: Eine Umfrage unter Mitgliedern des Ärzteverbandes Deutscher Allergologen (AeDA)
por: Dramburg, Stephanie, et al.
Publicado: (2021)

Evidence vs. efficacy in allergen-specific immunotherapy: Considerations using the example of tradable products in Germany
por: Brehler, Randolf, et al.
Publicado: (2016)

Placebo effects in allergen immunotherapy: an experts’ opinion
por: Frew, Anthony J., et al.
Publicado: (2018)

Allergen exposure chambers: implementation in clinical trials in allergen immunotherapy
por: Pfaar, O., et al.
Publicado: (2020)

Allergen immunotherapy during the COVID‐19 pandemic—A survey of the German Society for Allergy and Clinical Immunology
por: Pfaar, Oliver, et al.
Publicado: (2022)

Real-life evidence in allergen immunotherapy: Moving forward with mHealth apps
por: Sousa-Pinto, Bernardo, et al.
Publicado: (2023)

Allergy immunotherapy with a hypoallergenic recombinant birch pollen allergen rBet v 1-FV in a randomized controlled trial
por: Klimek, Ludger, et al.
Publicado: (2015)

EAACI Allergen Immunotherapy User's Guide
por: Alvaro‐Lozano, Montserrat, et al.
Publicado: (2020)

Vaccination against infectious agents and allergen-specific immunotherapy: A critical analysis
por: Worm, Margitta, et al.
Publicado: (2023)

Adherence in allergen immunotherapy: Current situation and future implications
por: Gehrt, Francesca, et al.
Publicado: (2022)

Molecular Diagnosis of Allergy: The Pediatric Perspective
por: Dramburg, Stephanie, et al.
Publicado: (2019)

The impact of a digital wheeze detector on parental disease management of pre-school children suffering from wheezing—a pilot study
por: Dramburg, Stephanie, et al.
Publicado: (2021)

Clinical trials in allergen immunotherapy in the age group of children and adolescents: current concepts and future needs
por: Pfaar, O., et al.
Publicado: (2020)

Jetzt teilnehmen!
por: Klimek, Ludger, et al.
Publicado: (2020)

Mechanisms of Allergen Immunotherapy and Potential Biomarkers for Clinical Evaluation
por: Sahiner, Umit M., et al.
Publicado: (2023)

The placebo effect in allergen-specific immunotherapy trials
por: Narkus, Annemie, et al.
Publicado: (2013)

Is The Allergen Really Needed in Allergy Immunotherapy?
por: Kündig, Thomas M., et al.
Publicado: (2014)

Real‐world evidence for the long‐term effect of allergen immunotherapy: Current status on database‐derived European studies
por: Vogelberg, Christian, et al.
Publicado: (2022)

Nanoparticle–allergen complexes for allergen immunotherapy
por: Di Felice, Gabriella, et al.
Publicado: (2017)

Clinical trials in allergen immunotherapy: current concepts and future needs
por: Pfaar, O., et al.
Publicado: (2018)

Mite-Allergic Rhinitis: How to Evaluate Clinical Efficacy in Allergen-Specific Immunotherapy Trials?
por: Pfaar, Oliver, et al.
Publicado: (2015)

A prospective study comparing the efficacy and safety of two sublingual birch allergen preparations
por: Klimek, Ludger, et al.
Publicado: (2014)

111 years of allergen-immunotherapy: A long and successful history of the only available disease-modifier in allergic diseases
por: Gutermuth, Jan, et al.
Publicado: (2022)

The Potential of Clinical Decision Support Systems for Prevention, Diagnosis, and Monitoring of Allergic Diseases
por: Dramburg, Stephanie, et al.
Publicado: (2020)

Digital technologies for an improved management of respiratory allergic diseases: 10 years of clinical studies using an online platform for patients and physicians
por: Tripodi, Salvatore, et al.
Publicado: (2020)

Safety and effect on reported symptoms of depigmented polymerized allergen immunotherapy: a retrospective study of 2927 paediatric patients
por: Pfaar, Oliver, et al.
Publicado: (2015)

COVID-19 vaccination and allergen immunotherapy (AIT) – A position paper of the German Society for Applied Allergology (AeDA) and the German Society for Allergology and Clinical Immunology (DGAKI)
por: Klimek, Ludger, et al.
Publicado: (2021)

Comparison of allergen immunotherapy practice patterns in inhalant allergies in the United States of America and Europe: Similarities and differences 2023
por: Pfaar, Oliver, et al.
Publicado: (2023)

Allergen immunotherapy for allergic asthma: a systematic overview of systematic reviews
por: Asamoah, Felix, et al.
Publicado: (2017)

Persistence in allergen immunotherapy: A longitudinal, prescription data‐based real‐world analysis
por: Pfaar, Oliver, et al.
Publicado: (2023)

COVID‐19 pandemic and allergen immunotherapy—an EAACI survey
por: Pfaar, Oliver, et al.
Publicado: (2021)

Sublingual Immunotherapy with a Five-Grass Pollen Tablet in Adult Patients with Allergic Rhinitis: An Open, Prospective, Noninterventional, Multicenter Study
por: Pfaar, Oliver, et al.
Publicado: (2015)

CpG Adjuvant in Allergen-Specific Immunotherapy: Finding the Sweet Spot for the Induction of Immune Tolerance
por: Montamat, Guillem, et al.
Publicado: (2021)

An EAACI “European Survey on Adverse Systemic Reactions in Allergen Immunotherapy (EASSI)”: the methodology
por: Calderón, Moises A, et al.
Publicado: (2014)

A high‐dose, depigmented polymerized birch pollen extract for subcutaneous allergen immunotherapy has a favourable efficacy/safety ratio
por: Pfaar, Oliver, et al.
Publicado: (2023)

Immunology of allergen immunotherapy
por: Rahman, Rifat S, et al.
Publicado: (2022)

Allergen-specific immunotherapy
por: Moote, William, et al.
Publicado: (2011)

Allergen immunotherapy in pregnancy
por: Oykhman, Paul, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_30f98errjeimo2jnm928dkhvc9